SGLT2 Inhibitor Therapy for Transthyretin Amyloid Cardiomyopathy: Early Tolerance and Clinical Response to DapagliflozinStephan Dobner, Lukas Hunziker, Christoph Gräni et al.|ESC Heart Failure|2022Cited by 61